刊名:Journal of Cancer Research and Clinical Oncology
出版年:2016
出版时间:January 2016
年:2016
卷:142
期:1
页码:295-304
全文大小:462 KB
参考文献:Adelstein DJ, Leblanc M (2006) Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? J Clin Oncol 24:2624–2628PubMed CrossRef Ang KK et al (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571–578PubMed CrossRef Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709PubMed CrossRef Charlson ME, Pompei P, Ales KL, Mackenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chr Dis 40:373–383CrossRef Chen TC et al (2013) The clinical predictive factors for subsequent distant metastasis in patients with locoregionally advanced oral squamous cell carcinoma. Oral Oncol 49(4):367–373PubMed CrossRef Dragovic AF, Caudell JJ, Spencer SA, Carroll WR, Nabell LA, Bonner JA (2013) Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer. Head Neck 35:381–387PubMed CrossRef Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer Staging Manual, 7th edn. NY, Springer, New York, pp 21–78 Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359:1143–1154PubMed CrossRef Hellman S (1994) Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol 12:2229–2234PubMed Huang SH et al (2013) Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 49:79–85PubMed CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMed CrossRef Kim JW et al (2013) (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma. Br J Cancer 109:2973–2979PubMed PubMedCentral CrossRef Kramer S, Marcial VA, Pajak TF, MacLean CJ, Davis LW (1986) Prognostic factors for loco/regional control and metastasis and the impact on survival. Int J Radiat Oncol Biol Phys 12:573–578PubMed CrossRef Leon X, Quer M, Orus C, Del Prado Venegas M, Lopez M (2000) Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22:680–686PubMed CrossRef Liao CT et al (2007) Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110:1501–1508PubMed CrossRef McBride SM, Busse PM, Clark JR, Wirth LJ, Ancukiewicz M, Chan AW (2014) Long-term survival after distant metastasis in patients with oropharyngeal cancer. Oral Oncol 50:208–212PubMed CrossRef Shiono S et al (2009) Pulmonary metastasectomy for pulmonary metastases of head and neck squamous cell carcinomas. Ann Thorac Surg 88:856–860PubMed CrossRef Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29PubMed CrossRef Vermorken JB et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127PubMed CrossRef Wedman J et al (1996) Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck 18:311–316PubMed CrossRef Winter H et al (2008) Does surgical resection of pulmonary metastases of head and neck cancer improve survival? Ann Surg Oncol 15:2915–2926PubMed CrossRef Xu GZ, Guan DJ, He ZY (2011) (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol 47:560–565PubMed CrossRef Yao M et al (2012) Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 83:684–689PubMed CrossRef Yi JS et al (2012) 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. J Surg Oncol 106:708–712PubMed CrossRef
作者单位:Ho-Seob Kang (1) Jong-Lyel Roh (1) Min-Ju Kim (2) Kyung-Ja Cho (3) Sang-wook Lee (4) Sung-Bae Kim (5) Seung-Ho Choi (1) Soon Yuhl Nam (1) Sang Yoon Kim (1)
1. Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea 2. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea 3. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea 4. Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea 5. Department of Internal Medicine (Oncology), Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea
刊物类别:Medicine
刊物主题:Medicine & Public Health Oncology Cancer Research Internal Medicine Hematology
出版者:Springer Berlin / Heidelberg
ISSN:1432-1335
文摘
Purpose Distant metastasis (DM) of head and neck squamous cell carcinoma (HNSCC) is not common but remains a substantial problem. Here, we evaluated factors predictive of long-term survival in HNSCC patients presenting with DM after initial definitive treatment.